학술논문
587P Short lead time and high rates of concomitant radiographic recurrences for ctDNA-based minimal residual disease assays colorectal cancer (CRC) during surveillance: Results from the MD Anderson INTERCEPT program
Document Type
Abstract
Author
Source
In Annals of Oncology October 2023 34 Supplement 2:S427-S427
Subject
Language
ISSN
0923-7534